Search Results - "Premeaux, Thomas A"

Refine Results
  1. 1

    The latent HIV reservoir: current advances in genetic sequencing approaches by Moar, Preeti, Premeaux, Thomas A, Atkins, Andrew, Ndhlovu, Lishomwa C

    Published in mBio (31-10-2023)
    “…Multiple cellular HIV reservoirs in diverse anatomical sites can undergo clonal expansion and persist for years despite suppressive antiretroviral therapy,…”
    Get full text
    Journal Article
  2. 2

    Plasma inflammatory biomarkers link to diffusion tensor imaging metrics in virally suppressed HIV-infected individuals by Chang, Kevin, Premeaux, Thomas A., Cobigo, Yann, Milanini, Benedetta, Hellmuth, Joanna, Rubin, Leah H., Javandel, Shireen, Allen, Isabel, Ndhlovu, Lishomwa C., Paul, Robert, Valcour, Victor

    Published in AIDS (London) (01-02-2020)
    “…OBJECTIVE:Inflammation may contribute to brain white matter health in people living with HIV who report cognitive symptoms despite adherence to combination…”
    Get full text
    Journal Article
  3. 3

    Alterations in circulating immunoregulatory proteins discriminate poor CD4 T lymphocyte trajectories in people with HIV on suppressive antiretroviral therapy by Moar, Preeti, Bowler, Scott, Landay, Alan L, Gianella, Sara, Ndhlovu, Lishomwa C, Premeaux, Thomas A

    Published in mBio (17-09-2024)
    “…Despite the success in the management of HIV with antiretroviral therapy (ART), people with HIV (PWH) have a heightened state of immune activation and…”
    Get full text
    Journal Article
  4. 4

    Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection by Yeung, Stephen T., Premeaux, Thomas A., Du, Li, Niki, Toshiro, Pillai, Satish K., Khanna, Kamal M., Ndhlovu, Lishomwa C.

    Published in Frontiers in immunology (17-10-2022)
    “…SARS-CoV-2 remains a global health crisis even with effective vaccines and the availability of FDA approved therapies. Efforts to understand the complex…”
    Get full text
    Journal Article
  5. 5

    Multiplex Analysis of Cytokines and Chemokines in Persons Aging With or Without HIV by Kroll, Kyle W, Woolley, Griffin, Terry, Karen, Premeaux, Thomas A, Shikuma, Cecilia M, Corley, Michael J, Bowler, Scott, Ndhlovu, Lishomwa C, Reeves, R Keith

    Published in AIDS research and human retroviruses (01-07-2023)
    “…People with HIV (PWH) on combination antiretroviral therapy (cART) are living longer lives due to modern cART advances and increased routine medical care. The…”
    Get more information
    Journal Article
  6. 6

    Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies by Premeaux, Thomas A, Yeung, Stephen T, Bukhari, Zaheer, Bowler, Scott, Alpan, Oral, Gupta, Raavi, Ndhlovu, Lishomwa C

    Published in Frontiers in immunology (21-02-2022)
    “…Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a significant global health emergency…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research by Premeaux, Thomas A, Mediouni, Sonia, Leda, Ana, Furler, Robert L, Valente, Susana T, Fine, Howard A, Nixon, Douglas F, Ndhlovu, Lishomwa C

    Published in mBio (31-08-2021)
    “…Long-term effective use of antiretroviral therapy (ART) among people with HIV (PWH) has significantly reduced the burden of disease, yet a cure for HIV has not…”
    Get full text
    Journal Article
  9. 9

    Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling by Colomb, Florent, Giron, Leila B, Premeaux, Thomas A, Mitchell, Brooks I, Niki, Toshiro, Papasavvas, Emmanouil, Montaner, Luis J, Ndhlovu, Lishomwa C, Abdel-Mohsen, Mohamed

    Published in Frontiers in immunology (20-02-2019)
    “…Endogenous plasma levels of the immunomodulatory carbohydrate-binding protein galectin-9 (Gal-9) are elevated during HIV infection and remain elevated after…”
    Get full text
    Journal Article
  10. 10

    Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide by Baumer, Yvonne, Farmer, Nicole, Premeaux, Thomas A, Wallen, Gwenyth R, Powell-Wiley, Tiffany M

    Published in Frontiers in public health (08-10-2020)
    “…It is evident that health disparities exist during the COVID-19 pandemic, a pandemic caused by the novel coronavirus SARS-CoV-2. Underlying reasons for…”
    Get full text
    Journal Article
  11. 11

    Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy by Premeaux, Thomas A, Javandel, Shireen, Hosaka, Kalei R J, Greene, Meredith, Therrien, Nicholas, Allen, Isabel E, Corley, Michael J, Valcour, Victor G, Ndhlovu, Lishomwa C

    Published in Frontiers in immunology (30-06-2020)
    “…The prevalence of age-related comorbidities is increased in people living with HIV, even in those well-controlled on combination antiretroviral therapy (ART)…”
    Get full text
    Journal Article
  12. 12

    Machine learning models based on fluid immunoproteins that predict non-AIDS adverse events in people with HIV by Premeaux, Thomas A., Bowler, Scott, Friday, Courtney M., Moser, Carlee B., Hoenigl, Martin, Lederman, Michael M., Landay, Alan L., Gianella, Sara, Ndhlovu, Lishomwa C.

    Published in iScience (21-06-2024)
    “…Despite the success of antiretroviral therapy (ART), individuals with HIV remain at risk for experiencing non-AIDS adverse events (NAEs), including…”
    Get full text
    Journal Article
  13. 13

    Hiding in plain sight - platelets, the silent carriers of HIV-1 by Baumer, Yvonne, Weatherby, Tina M, Mitchell, Brooks I, SahBandar, Ivo N, Premeaux, Thomas A, Michelle L, D'Antoni, Gutierrez-Huerta, Cristhian A, Powell-Wiley, Tiffany M, Brown, Timothy R, Boisvert, William A, Shikuma, Cecilia M, Ndhlovu, Lishomwa C

    Published in Platelets (Edinburgh) (17-11-2021)
    “…There are approximately 38 million people globally living with Human immunodeficiency virus 1 (HIV-1) and given the tremendous success of combination…”
    Get full text
    Journal Article
  14. 14

    Targeting the C-terminus of galectin-9 induces mesothelioma apoptosis and M2 macrophage depletion by Bertino, Pietro, Premeaux, Thomas A., Fujita, Tsuyoshi, Haun, Brien K., Marciel, Michael P., Hoffmann, Fukun W., Garcia, Alan, Yiang, Haining, Pastorino, Sandra, Carbone, Michele, Niki, Toshiro, Berestecky, John, Hoffmann, Peter R., Ndhlovu, Lishomwa C.

    Published in Oncoimmunology (03-08-2019)
    “…Galectin-9 has emerged as a promising biological target for cancer immunotherapy due to its role as a regulator of macrophage and T-cell differentiation. In…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Decrypting biological hallmarks of aging in people with HIV by Premeaux, Thomas A., Ndhlovu, Lishomwa C.

    Published in Current opinion in HIV & AIDS (01-09-2023)
    “…HIV infection adds further complexity to the heterogenous process of aging. In this focused review, we examine and discuss recent advances to better elucidate…”
    Get full text
    Journal Article